Kirkland Advises Apotex on Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses

Kirkland & Ellis advised Apotex, the largest Canadian based pharmaceutical company, on a strategic transaction with Cumberland Pharmaceuticals Inc., a U.S. based specialty pharmaceutical company, to integrate Cumberland’s U.S. branded businesses into Apotex. Under the terms of the agreement, Apotex will add a portfolio of branded medicines to its U.S. business. The transaction is expected to significantly expand Apotex’s U.S. specialty and hospital focused business with a diversified basket of products across acute care, oncology, infectious disease and gastroenterology. 

Read the transaction press release

The Kirkland team included corporate lawyers Ngozi Nezianya, Matt Arenson, Matt Schoener and Jacob Groppel; and technology and IP transactions lawyers Aaron Lorber, Matt Darch, Michelle Kelrikh and Sarah Alpert.